Literature DB >> 18499095

Asymmetrical distributions of muscarinic receptor binding in the hippocampus of female rats.

Samuel C Wolff1, Zuzana Hruska, Lieuko Nguyen, Gary P Dohanich.   

Abstract

Asymmetries in muscarinic receptor binding were investigated in the hippocampus of female rats by in vitro autoradiography. Coronal sections from 18 brains were incubated with the muscarinic receptor antagonist [3H]quinuclidinyl benzilate, the muscarinic M1 receptor antagonist [3H]pirenzepine, or the muscarinic M2 receptor antagonist [3H]AF-DX 384. Binding of these radioligands was higher on the right than the left side of CA1, CA3, and dentate gyrus in almost every brain confirming hemispheric asymmetry at the neurochemical level. The ovarian hormone, estradiol, did not alter the asymmetry in muscarinic binding. Neurochemical asymmetries within hippocampal subfields may have implications for physiological and behavioral functions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499095     DOI: 10.1016/j.ejphar.2008.04.002

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Cholinergic left-right asymmetry in the habenulo-interpeduncular pathway.

Authors:  Elim Hong; Kirankumar Santhakumar; Courtney A Akitake; Sang Jung Ahn; Christine Thisse; Bernard Thisse; Claire Wyart; Jean-Marie Mangin; Marnie E Halpern
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-10       Impact factor: 11.205

2.  Autoradiography of 3H-pirenzepine and 3H-AFDX-384 in Mouse Brain Regions: Possible Insights into M1, M2, and M4 Muscarinic Receptors Distribution.

Authors:  Paulina Valuskova; Vladimir Farar; Sandor Forczek; Iva Krizova; Jaromir Myslivecek
Journal:  Front Pharmacol       Date:  2018-02-20       Impact factor: 5.810

3.  Experience enhances gamma oscillations and interhemispheric asymmetry in the hippocampus.

Authors:  Yoshiaki Shinohara; Aki Hosoya; Hajime Hirase
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.